ROZA LISS: Open Payments
NPI 1235362781 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 15 payments from 6 companies in 2025. Trend: 2023 $1,229 · 2024 $982 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $177 |
| Novo Nordisk Inc | 2 | $140 |
| Astellas Pharma US Inc | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Amgen Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $15 |
Products named: Wegovy, Veozah, QULIPTA, AIRSUPRA, EVENITY, Ozempic, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across MD — which companies pay providers there.
